PMID: 3215320Aug 1, 1988Paper

Three years experience with denaturated venous homografts as an arterial substitute: a clinical, pathological and immunological study

European Journal of Vascular Surgery
R W van Reedt DortlandT Theodorides

Abstract

Over a three-year-period 105 peripheral arterial reconstructions were performed using a denaturated venous homograft in a group of patients with no suitable autologous vein. A retrospective analysis has been carried out to investigate the patency rate of this graft. After three years 64% of all grafts are functioning well (according to the Life Table Method, Kaplan & Meyer). No significant differences in patency rates were found between reversed autologous veins and the material tested in this study but analysis of grafts removed after failure showed obstruction due to thrombosis or aneurysmal dilatation. No evidence of an immune response to the grafts was seen.

References

May 1, 1978·Archives of Surgery·M StephenJ Wong
Mar 1, 1976·Vascular Surgery·R R KraegerH B Barner
Jun 1, 1971·Annals of Surgery·J L OchsnerG L Leonard
May 1, 1967·Archives of Surgery·D L MortonE J Wylie

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Aneurysm

Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.